首页> 外国专利> molecule malignancy in melanocytic lesions

molecule malignancy in melanocytic lesions

机译:黑素细胞病变中的分子恶性肿瘤

摘要

melanocyte-containing sample (such as a nevus or other pigmented lesions) is, whether benign, Method for determining whether a primary melanoma is disclosed. These methods, a biological sample obtained from a subject, detecting the expression of genes which are at least two disclosed (at the molecular level, for example, mRNA, miRNA, or a protein) may involve. In addition, array and kits may be used in conjunction with the present method is also presented. The biological samples (such as melanocytes containing sample), arrays and kits for diagnosing as nevi or primary melanoma benign also disclosed.
机译:含黑色素细胞的样本(例如痣或其他色素性病变)是否良性,是确定是否披露原发性黑色素瘤的方法。这些方法是从受试者获得的生物学样品,其检测至少公开的两个基因的表达(在分子水平上,例如,mRNA,miRNA或蛋白质)。另外,还提出了可与本方法结合使用的阵列和试剂盒。还公开了用于诊断为痣或原发性黑色素瘤良性的生物学样品(例如含有样品的黑色素细胞),阵列和试剂盒。

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号